AbbVie · 1 month ago
Director, US Market Access Pipeline
Irvine, CA, US
Full-time
Onsite
Mid Level
2+ years expAbbVie is dedicated to discovering and delivering innovative medicines and solutions for serious health issues. The Director, US Market Access Pipeline will lead the U.S. market access strategy development for early pipeline priority assets, integrating payer insights into the drug development process.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Responsible and accountable for the access point of view and creation of Integrated Asset Strategies, Early Integrated Value Propositions and Disease Area Strategies within the AbbVie Portfolio
Collaborate with teams across BUs, PCS, IMAP, Medical, HEOR, CBSO, IRA, R&D, and others to ensure the value drivers of USMAx decision makers are incorporated into pipeline commercialization strategies
Inform clinical development programs so that endpoints and evidence generation plans (i.e., clinical, economic, and humanistic outcomes) support optimized patient access for new and novel therapies
Ensure project resource needs are met; secure and allocate budgets across asset assignments to meet critical enterprise goals for pipeline assets
Ensure that deep USMAx insights are embedded in all early pipeline strategies to support optimal asset development through the 1-7-5 model
Initiate market shaping in a timely fashion, ensuring a smooth hand-off to Directors, USMAx Marketing, for U.S. launch readiness preparation
Provide strong asset leadership, serving as the primary point of contact for USMAx Pipeline stakeholders aligned to that asset and disease area
Act as a critical partner to key internal stakeholders who drive early pipeline strategy, including U.S. Commercial Leadership, Asset Strategy Leadership, Pipeline Commercial Strategy Leadership, Medical Affairs/HEOR, and International Market Access and Pricing
Represent USMAx Early Pipeline as a subject matter expert at governance reviews as needed (e.g., TASC, LMG, DRC, etc.)
Contribute critical strategic thinking to inform access and pricing assumptions to create accurate, market-driven LRP assumptions for pipeline assets and business development (as assigned)
Serve as pipeline lead, accountable for USMAx financial LRP and strategic LRP assumptions for all assigned assets
Work closely across USMAx teams and stay up to date on channel dynamics and priorities
Partner with IRA and cross-strategy teams to ensure optimal asset planning and inform strategic planning and decision-making
Demonstrate enterprise mindset and leadership, act as a role model and example across the team
Qualification
Required
2+ years of US market access experience preferred
Proven ability to influence without authority and navigate complex and ambiguous organizational dynamics with sound decision-making
Subject matter expertise relevant to commercial and government payers is required
U.S. market access experience across several roles is preferred
Expertise in developing compelling early payer value propositions preferred
Experience leading primary and secondary payer research projects to inform payer insights, market value drivers, and channel strategies
Knowledge of government contracting, acquisition trends, and role of market access stakeholders across the patient journey
Experience in pipeline development and/or market access launches, ideally in the assigned disease area
Experience with pharmacy and medical benefit products, pricing, and GtN (Gross-to-Net) influences as well as differing acquisition models (e.g., Buy & Bill, DTP)
Previous disease area experience and knowledge of competitive environment as well as and clinical trial endpoints is preferred
Strong strategic thinking, communication skills, and executive presence are required
Financial acumen and ability to comprehend complex planning scenarios required
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase